继发性甲状旁腺功能亢进行甲状旁腺切除并前臂移植方法的对比分析

徐栋, 费梦嘉, 王家东. 继发性甲状旁腺功能亢进行甲状旁腺切除并前臂移植方法的对比分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(5): 428-432. doi: 10.13201/j.issn.2096-7993.2020.05.010
引用本文: 徐栋, 费梦嘉, 王家东. 继发性甲状旁腺功能亢进行甲状旁腺切除并前臂移植方法的对比分析[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(5): 428-432. doi: 10.13201/j.issn.2096-7993.2020.05.010
XU Dong, FEI Mengjia, WANG Jiadong. Comparative analysis of surgical methods for parathyroidectomy and forearm transplantation in secondary hyperparathyroidism[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(5): 428-432. doi: 10.13201/j.issn.2096-7993.2020.05.010
Citation: XU Dong, FEI Mengjia, WANG Jiadong. Comparative analysis of surgical methods for parathyroidectomy and forearm transplantation in secondary hyperparathyroidism[J]. J Clin Otorhinolaryngol Head Neck Surg, 2020, 34(5): 428-432. doi: 10.13201/j.issn.2096-7993.2020.05.010

继发性甲状旁腺功能亢进行甲状旁腺切除并前臂移植方法的对比分析

详细信息

Comparative analysis of surgical methods for parathyroidectomy and forearm transplantation in secondary hyperparathyroidism

More Information
  • 目的 比较继发性甲状旁腺功能亢进患者接受甲状旁腺全切除后,采用改良的针筒前臂定量注射法与前臂切口肱桡肌内移植法的疗效。方法 接受甲状旁腺全切除的继发性甲状旁腺功能亢进患者152例,按照术中不同的前臂移植甲状旁腺方式分为肱桡肌切开移植组和针筒前臂定量移植组。统计手术操作时长、术前术后甲状旁腺激素水平、血钙等指标并进行对照分析。结果 2组患者在实验室检查方面差异无统计学意义,但改良的针筒前臂定量注射法操作更为便捷,针筒前臂定量移植组术后甲状旁腺激素水平恢复时间(3个月)较肱桡肌切开移植组(6个月)更短(P=0.03)。2组患者在移植后复发情况的差异无统计学意义。结论 改良的针筒前臂定量注射法移植甲状旁腺,操作相对简单、更节省时间、可使移植的甲状旁腺更快发挥功能,值得广泛运用。
  • 加载中
  • 图 1  改良的1 ml针筒前臂定量注射法移植甲状旁腺

    图 2  Kaplan-Meier模型曲线

    表 1  针筒前臂定量移植组和肱桡肌切开移植组临床及实验室数据比较

    临床及检查项目 针筒前臂定量移植 肱桡肌切开移植 P
    例数 100 42
    年龄/岁 55(35~74) 56(39~75) 0.297
    性别 0.352
      男 46(46.0) 17(40.5)
      女 54(54.0) 25(59.5)
    透析方式 0.471
      血透 82(82.0) 35(83.3)
      腹透 17(17.0) 7(16.7)
      不明 1(1.0) 0(0)
    透析年限/年 8(1~23) 7(2~30) 0.442
    手术用时/min 99(60~252) 107(60~240) 0.352
    术前PTH/(pg·ml-1) 1 324(347~2 500) 1 204(390~2 500) 0.243
    术后PTH/(pg·ml-1) 0.287
       < 12 62(62.0) 24(57.1)
      12~72 29(29.0) 13(31.0)
      >72~300 6(6.0) 2(4.8)
      >300 3(3.0) 3(7.1)
    术前校正血钙/(mmol·L-1) 2.74(2.23~3.75) 2.76(2.45~3.33) 0.591
    术后校正血钙/(mmol·L-1) 2.47(2.08~3.44) 2.45(1.95~2.94) 0.214
    术后葡萄糖酸钙静脉用量/g 8(6~26) 9(6~27) 0.397
    下载: 导出CSV
  • [1]

    张凌. 继发性甲状旁腺功能亢进的治疗策略[J]. 中华肾病研究电子杂志, 2015, 4(3): 5-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSB201503003.htm

    [2]

    Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism[J]. Lancet, 2018, 391(10116): 168-178. doi: 10.1016/S0140-6736(17)31430-7

    [3]

    Uhlig K, Berns JS, Kestenbaum B, et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder(CKD-MBD)[J]. Am J Kidney Dis, 2010, 55(5): 773-799. doi: 10.1053/j.ajkd.2010.02.340

    [4]

    Ng JC, Wang W, Chua MJ, et al. Subcutaneous injection is a simple and reproducible option to restore parathyroid function after total parathyroidectomy in patients with secondary hyperparathyroidism[J]. Surgery, 2014, 155(4): 682-688. doi: 10.1016/j.surg.2013.12.019

    [5]

    Anderson K Jr, Ruel E, Adam MA, et al. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes[J]. Am J Surg, 2017, 214(5): 914-919. doi: 10.1016/j.amjsurg.2017.07.018

    [6]

    Lorenz K, Bartsch DK, Sancho JJ, et al. Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the European Society of Endocrine Surgeons[J]. Langenbecks Arch Surg, 2015, 400(8): 907-927. doi: 10.1007/s00423-015-1344-5

    [7]

    Madorin C, Owen RP, Fraser WD, et al. The surgical management of renal hyperparathyroidism[J]. Eur Arch Otorhinolaryngol, 2012, 269(6): 1565-1576. doi: 10.1007/s00405-011-1833-2

    [8]

    Schlosser K, Bartsch DK, Diener MK, et al. Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism[J]. Ann Surg, 2016, 264(5): 745-753. doi: 10.1097/SLA.0000000000001875

    [9]

    殷德涛, 余坤. 继发性甲状旁腺功能亢进症的外科治疗[J]. 中国普通外科杂志, 2016, 25(5): 631-634. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201605001.htm

    [10]

    Hsu YC, Hung CJ. Intramuscular and subcutaneous forearm parathyroid autograft hyperplasia in renal dialysis patients: A retrospective cohort study[J]. Surgery, 2015, 158(5): 1331-1338. doi: 10.1016/j.surg.2015.04.027

    [11]

    Gopalakrishna NI, Shaha AR. Complications of thyroid surgery: prevention and management[J]. Minerva Chir, 2010, 65(1): 71-82.

    [12]

    Tominaga Y, Matsuoka S, Uno N, et al. Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients[J]. World J Surg, 2010, 34(6): 1312-1317. doi: 10.1007/s00268-010-0412-9

    [13]

    Agha A, Loss M, Schlitt HJ, et al. Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects[J]. Eur Arch Otorhinolaryngol, 2012, 269(5): 1519-1525. doi: 10.1007/s00405-011-1776-7

    [14]

    Messa P, Castelnovo C, Scalamogna A. Calcimimetics in peritoneal dialysis patients[J]. Contrib Nephrol, 2012, 178: 143-149. doi: 10.1159/000337834

  • 加载中

(2)

(1)

计量
  • 文章访问数:  1080
  • PDF下载数:  342
  • 施引文献:  0
出版历程
收稿日期:  2019-08-28
刊出日期:  2020-05-05

目录